Suchergebnis | Hamburg Open Science

Facetten

72 Einträge gefunden

Influence of exogenous atrial natriuretic peptide on the nocturnal hypothalamic-pituitary-adrenal axis and sleep in healthy men.
2010 - Forschungsinformationssystem des UKE
The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype.
2009 - Forschungsinformationssystem des UKE
Increased DHEA and DHEA-S plasma levels in patients with post-traumatic stress disorder and a history of childhood abuse.
2009 - Forschungsinformationssystem des UKE
Does 5-HTTLPR genotype influence willingness to participate in panic challenges?
2009 - Forschungsinformationssystem des UKE
Cognitive impairment in major depression: association with salivary cortisol.
2009 - Forschungsinformationssystem des UKE
The organization of autobiographical and nonautobiographical memory in posttraumatic stress disorder (PTSD).
2009 - Forschungsinformationssystem des UKE
Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study.
2009 - Forschungsinformationssystem des UKE
A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
2008 - Forschungsinformationssystem des UKE
No effect of six weeks of treatment with escitalopram on mood in healthy volunteers--irrespective of genotype for the promoter of the serotonin transporter.
2008 - Forschungsinformationssystem des UKE
Words may not be enough! No increased emotional Stroop effect in obsessive-compulsive disorder.
2008 - Forschungsinformationssystem des UKE
Mineralocorticoid receptors in brain, in health and disease: possibilities for new pharmacotherapy.
1. Kellner, Michael
2. Wiedemann, Klaus
2008 - Forschungsinformationssystem des UKE
Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition.
2007 - Forschungsinformationssystem des UKE
Aripiprazole in a therapy-resistant patient with borderline personality and post-traumatic stress disorder.
1. Kellner, Michael
2007 - Forschungsinformationssystem des UKE
Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
2006 - Forschungsinformationssystem des UKE
Verbal and nonverbal memory functioning in posttraumatic stress disorder (PTSD).
2006 - Forschungsinformationssystem des UKE
Mineralocorticoid receptor function in posttraumatic stress disorder after pretreatment with metyrapone.
2006 - Forschungsinformationssystem des UKE
Effects of a metabotropic glutamate(2/3) receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results.
2005 - Forschungsinformationssystem des UKE
Extent, profile and specificity of visuospatial impairment in obsessive-compulsive disorder (OCD).
2005 - Forschungsinformationssystem des UKE
Valproate monotherapy in the treatment of civilian patients with non-combat-related posttraumatic stress disorder: an open-label study.
2004 - Forschungsinformationssystem des UKE
Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings.
2004 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Influence of exogenous atrial natriuretic peptide on the nocturnal hypothalamic-pituitary-adrenal axis and sleep in healthy men.

The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype.

Increased DHEA and DHEA-S plasma levels in patients with post-traumatic stress disorder and a history of childhood abuse.

Does 5-HTTLPR genotype influence willingness to participate in panic challenges?

Cognitive impairment in major depression: association with salivary cortisol.

The organization of autobiographical and nonautobiographical memory in posttraumatic stress disorder (PTSD).

Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study.

A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.

No effect of six weeks of treatment with escitalopram on mood in healthy volunteers--irrespective of genotype for the promoter of the serotonin transporter.

Words may not be enough! No increased emotional Stroop effect in obsessive-compulsive disorder.

Mineralocorticoid receptors in brain, in health and disease: possibilities for new pharmacotherapy.

Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition.

Aripiprazole in a therapy-resistant patient with borderline personality and post-traumatic stress disorder.

Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.

Verbal and nonverbal memory functioning in posttraumatic stress disorder (PTSD).

Mineralocorticoid receptor function in posttraumatic stress disorder after pretreatment with metyrapone.

Effects of a metabotropic glutamate(2/3) receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results.

Extent, profile and specificity of visuospatial impairment in obsessive-compulsive disorder (OCD).

Valproate monotherapy in the treatment of civilian patients with non-combat-related posttraumatic stress disorder: an open-label study.

Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings.